drugset / Trial / NCT06660693
Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to examine patients with acute severe UC who are refractory to intravenous corticosteroids and determine whether a strategy of using upadacitinib first followed by infliximab in upadacitinib non-responders is non-inferior to conventional management with infliximab only.
Timeline
- Start
- 2025-04-16
- Primary completion
- 2027-05
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Upadacitinib | Small molecule | 45 mg | Oral |